Endometriosis

Disease

Related News

Japan's Regenerative Cell Therapy Push Advances With Regulatory Review, Market Growth, and New Patents

Japan's health ministry panel is reviewing two regenerative cell therapies for Parkinson's disease and heart failure, testing the country's push to build a domestic cell-based treatment industry. Japan's cell culture market is projected to reach USD 2.34 billion by 2031, driven by government support and favorable regulatory pathways. Australian firm Cartherics secured a Japanese patent for its iPSC-based immune cell therapies.

Related Clinical Trials

NCT ID Title Status Phase
NCT07749053

Guangdong Provincial Endometriosis Clinical Research Cohort

RECRUITING
NCT07740759

Impact of Educational Videos on Pre-operative Anxiety

ENROLLING_BY_INVITATION NA
NCT07733583

Pelvic Floor Physical Therapy and Exercise for Women With Endometriosis and Chronic Pelvic Pain

RECRUITING NA
NCT07731776

Improving Access to Pelvic Health Physiotherapy for Endometriosis

RECRUITING
NCT07728695

Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain

RECRUITING PHASE1/PHASE2
NCT07713797

Biomarkers for Endometriosis

RECRUITING
NCT07713108

Pelvic Floor Muscle Function and Endometriosis-Related Pelvic Pain

RECRUITING
NCT07711743

Histological Assessment of Tissue Penetration Depth of Argon Beam Coagulation in Ovarian Endometriomas

RECRUITING NA
NCT07693283

Expression of Target in Endometriotic Lesions

RECRUITING
NCT07686783

Ovarian Reserve After Laparoscopic Cystectomy for Endometriotic and Non-Endometriotic Cysts

RECRUITING NA